MetaCap

Dianthus Therapeutics Statistics

NASDAQ: DNTHHealth CareBiotechnology: Pharmaceutical PreparationsUSD

84.55-0.28 (-0.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Dianthus Therapeutics by the numbers

Dianthus Therapeutics has a market capitalization of $4.76 billion based on 56.31M shares outstanding. With trailing EPS of $-4.08, Dianthus Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.1% below its 50-day average and 3.7% below its 200-day average.

Average daily trading volume is 848.96K shares, or about $71.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

DNTH valuation vs. peer median

DNTH compared with the median of 8 peer companies
MetricDNTHPeer medianDifference
Market cap$4.76B$4.75B+0%
Avg. volume848.96K1.94M-56%

Peer median across 8 companies: ERAS, PTCT, LQDA, COGT, TVTX, MANE, IONS, BLTE.

Valuation

Price / sales (latest FY)
2,338.53
EPS (TTM)
$-4.08

Price and trading

Previous close
84.83
Open
83.62
Day range
82.58 – 85.67
52-week range
35.84 – 117.88
52-week change
+103.98%
Beta
—
Volume
784.84K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
4.76B
Forward Pe
-19.83
Eps
-4.08
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
117.88
Week52 Low
35.84
Avg Volume
848.96K
Shares Outstanding
56.31M
Ma50
86.37
Ma200
87.81
Earnings Date
Nov 4, 2026
Pct From52w High
-28.27%
Pct From52w Low
135.91%

Related